Allan Hallquist、Cary A. Presant、Robert E. Henry、Lyn Cates、Norman B. Purvis
ImmunoINTEL | Provides more accurate quantitation and characterization of all tumors and immune populations in tumor samples. |
ChemoINTEL | Accurately predict patient response to chemotherapy and provide more accurate clinical validation data. |
PathwayINTEL | Functional biomarkers that predict the outcome of targeted therapies are identified based on expression analysis of transduction pathway protein expression and activation status in the patient's tumor. |
融资轮次 | 融资日期 | 投资方 | 融资额度 |
---|---|---|---|
私募股权 | 2013-06 | 未披露 | $18M |